Cole Ryan 4

4 · Aurinia Pharmaceuticals Inc. · Filed May 20, 2026

AI-generated summary of this filing

Updated May 20, 2026

Aurinia (AUPH) COO Cole Ryan Receives Equity Award

What Happened

Cole Ryan, Chief Operating Officer of Aurinia Pharmaceuticals (AUPH), received equity awards on 2026-05-18 totaling 186,374 units: 116,144 performance stock units (PSUs) and 70,230 time‑based restricted stock units (RSUs). The Form 4 reports an acquisition price of $0.00 for both grants (typical for compensation awards). These are awards (compensation), not open‑market purchases or sales.

Key Details

Transaction date: 2026-05-18; Form 4 filed: 2026-05-20 (timely).
Reported acquisition price: $0.00 for both grants.
Total awarded: 186,374 units (116,144 PSUs + 70,230 RSUs).
Shares owned after transaction: Not specified in the provided filing details.
Footnote F1 (PSUs): Each PSU is a contingent right to one common share. 46,820 of the PSUs vest in four tranches upon the stock hitting four escalating price targets (each tranche subject to a one‑year retention period). 69,324 of the PSUs vest in two tranches at the 3‑ and 5‑year anniversaries if target prices are met before vesting.
Footnote F2 (time‑based RSUs): 33% of these RSUs vest on the 1‑year anniversary of the grant; the remaining 67% vest equally in monthly installments over the following two years.
Transaction type: Award/Grant (code A) — compensation, not a buy/sell.

Context

These awards are compensation and include performance‑based PSUs (which only convert to shares if price/vesting conditions are met) and standard time‑based RSUs. They do not represent an immediate cash purchase or sale of stock and therefore are not direct expressions of short‑term trading intent.

Form 4

Period: 2026-05-18

Chief Operating Officer

Transactions

Award
Common Stock
[F1]
2026-05-18+116,144→ 116,144 total
Award
Employee Stock Option (right to buy)
[F2]
2026-05-18+70,230→ 70,230 total
Exercise: $15.28Exp: 2036-05-18→ Common Stock (70,230 underlying)

Footnotes (2)

[F1]Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date.
[F2]33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.

Signature

/s/ Ryan Cole|2026-05-20

1 file